Grant: Agriculture and Agri-Food Canada Research Partnership
University of Guelph
$12,000.00
Examination of immunomodulatory effects of gut microbiota manipulations in the chicken
FY 2006-07
Summary
Food-borne pathogens, especially Salmonella spp. and Campylobacter jejuni, cause serious illness in humans. These two pathogens account for over 90% of all food poisoning cases worldwide and there are at least 17,000 reported cases of infections with these two bacteria in Canada every year. However, this might be an underestimate of the extent of the problem, as many cases remain unreported. It is estimated that each year, over 4 million cases of salmonellosis or campylobacteriosis occur in the US. Chickens may harbour these pathogens in their intestines and, as a result, play an important role in transmission of these pathogens to humans. Currently, several strategies exist for control of food-borne pathogens in chickens, including the use of probiotic bacteria. These bacteria are usually members of the gut bacterial community, which could exert a wide array of functions leading to reduction of gut colonization by disease causing bacteria, improved gut health, and enhancement of systemic and local immune responsiveness. Importantly, the use of antibiotics in poultry production as growth promotants is becoming increasingly restricted and will be eventually banned altogether. This signifies the need to identify antibiotic replacement strategies, such as probiotics, and to expand our understanding of their mode of action. Careful examination of immunological attributes of prebiotics will provide a platform for discovering novel prophylactic strategies against infectious diseases in chicken. Thus, the proposed studies are aimed at elucidating the mechanisms through which probiotics influence the chicken immune system. These studies will emphasize the immunological mechanisms of protection against gut colonization by Salmonella in the chicken. Findings of the proposed studies are expected to facilitate the establishment and maintenance of a safe food chain by reducing food-borne pathogen burden and shedding in poultry. In addition, other benefits such as reduction in the use of antibiotics and its ensuing effects on emergence of antibiotic-resistant strains of bacteria and presence of antibiotic residues in human food are expected.
Program
Agriculture and Agri-Food Canada Research Partnership
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
327872-2005
Name nom
Sharif, Shayan
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2005
Award amount
12000
Program id
AAFPJ
Program name en
Agriculture and Agri-Food Canada Research Partnership
Program name fr
Partenariat de recherche d'Agriculture et Agroalimentaire Canada
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Partie
2
Nb partie
2
Application title
Examination of immunomodulatory effects of gut microbiota manipulations in the chicken
Keyword
NA
Application summary
Food-borne pathogens, especially Salmonella spp. and Campylobacter jejuni, cause serious illness in humans. These two pathogens account for over 90% of all food poisoning cases worldwide and there are at least 17,000 reported cases of infections with these two bacteria in Canada every year. However, this might be an underestimate of the extent of the problem, as many cases remain unreported. It is estimated that each year, over 4 million cases of salmonellosis or campylobacteriosis occur in the US. Chickens may harbour these pathogens in their intestines and, as a result, play an important role in transmission of these pathogens to humans. Currently, several strategies exist for control of food-borne pathogens in chickens, including the use of probiotic bacteria. These bacteria are usually members of the gut bacterial community, which could exert a wide array of functions leading to reduction of gut colonization by disease causing bacteria, improved gut health, and enhancement of systemic and local immune responsiveness. Importantly, the use of antibiotics in poultry production as growth promotants is becoming increasingly restricted and will be eventually banned altogether. This signifies the need to identify antibiotic replacement strategies, such as probiotics, and to expand our understanding of their mode of action. Careful examination of immunological attributes of prebiotics will provide a platform for discovering novel prophylactic strategies against infectious diseases in chicken. Thus, the proposed studies are aimed at elucidating the mechanisms through which probiotics influence the chicken immune system. These studies will emphasize the immunological mechanisms of protection against gut colonization by Salmonella in the chicken. Findings of the proposed studies are expected to facilitate the establishment and maintenance of a safe food chain by reducing food-borne pathogen burden and shedding in poultry. In addition, other benefits such as reduction in the use of antibiotics and its ensuing effects on emergence of antibiotic-resistant strains of bacteria and presence of antibiotic residues in human food are expected.